Groundbreaking UK gene therapy offers hope after progress of three-year-old
SMRTR summary
Doctors report encouraging progress from the first patient to receive experimental gene therapy for Hunter syndrome. Three-year-old Oliver Chu no longer needs costly weekly treatments and shows dramatically improved speech, movement, and cognitive development.
SMRTR provides this summary for quick context. The original article belongs to The Guardian.
Read the original article